Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.

Source:http://linkedlifedata.com/resource/pubmed/id/15476273

Cancer 2004 Nov 15 101 10 2239-46

Download in:

View as

General Info

PMID
15476273